Abstract PS10-12: Integrated Safety Summary of Single Agent and Combination Margetuximab in Phase 1, 2, and 3 Studies of HER2-positive Advanced Cancers and Metastatic Breast Cancer (MBC)
Cancer Research（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined